A cross-sectional observation study regarding patients and their physician willingness to wait for driver mutation report in nonsmall-cell lung cancer
Background: Palliative chemotherapy +/− targeted therapy in accordance with mutation profile is the norm in nonsmall-cell lung cancer (NSCLC). The objective of this audit was to determine the proportion of patients and physicians, who are unwilling to wait for the mutation report and the reasons the...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2016-01-01
|
| Series: | Indian Journal of Medical and Paediatric Oncology |
| Subjects: | |
| Online Access: | http://www.ijmpo.org/article.asp?issn=0971-5851;year=2016;volume=37;issue=2;spage=74;epage=78;aulast=Joshi |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850217803876925440 |
|---|---|
| author | Amit Joshi Vijay M Patil Vanita Noronha Joydeep Ghosh Atanu Bhattacharjee Kumar Prabhash |
| author_facet | Amit Joshi Vijay M Patil Vanita Noronha Joydeep Ghosh Atanu Bhattacharjee Kumar Prabhash |
| author_sort | Amit Joshi |
| collection | DOAJ |
| description | Background: Palliative chemotherapy +/− targeted therapy in accordance with mutation profile is the norm in nonsmall-cell lung cancer (NSCLC). The objective of this audit was to determine the proportion of patients and physicians, who are unwilling to wait for the mutation report and the reasons thereof. Materials and Methods: All newly diagnosed NSCLC patients, post biopsy, seen at our center between November 2014 and January 2015 were included. The relationship between patient and physician decision and objective factors was explored by Fisher's exact test. The factors considered were Eastern Cooperative Oncology Group performance status (ECOG PS), the presence of a cough, hemoptysis, fatigue, and breathlessness. The agreement between patients and physician decision was tested by contingency table. Results: Out of 168 patients, 57 were unwilling to wait for driver mutation report (33.9% 95% confidence interval [CI] 27.2-41.4%). The most common reason provided by patients was symptomatic status (23, 40.1%). No other objective factor except PS (P = 0.00) was associated with patient's decision. In 56 patients (33.4% 95% CI 26.6-40.7%), physicians were unwilling to wait. Among the tested factors ECOG PS (P = 0.000), breathlessness (P = 0.00) and fatigue (P = 0.00) were associated with the decision of not waiting for the report. The percentage corrected value of contingency between patients and physician decision was 78.74%. Conclusion: At present, in our setup, nearly one-third of our NSCLC patients opt for immediate chemotherapy treatment and are unwilling to wait for mutation analysis report. The major reasons for such attitude is poor symptom control and deteriorating general condition. |
| format | Article |
| id | doaj-art-3804abad9dbe4d42aa1ae03d8b759d65 |
| institution | OA Journals |
| issn | 0971-5851 |
| language | English |
| publishDate | 2016-01-01 |
| publisher | Thieme Medical and Scientific Publishers Pvt. Ltd. |
| record_format | Article |
| series | Indian Journal of Medical and Paediatric Oncology |
| spelling | doaj-art-3804abad9dbe4d42aa1ae03d8b759d652025-08-20T02:07:58ZengThieme Medical and Scientific Publishers Pvt. Ltd.Indian Journal of Medical and Paediatric Oncology0971-58512016-01-01372747810.4103/0971-5851.180138A cross-sectional observation study regarding patients and their physician willingness to wait for driver mutation report in nonsmall-cell lung cancerAmit JoshiVijay M PatilVanita NoronhaJoydeep GhoshAtanu BhattacharjeeKumar PrabhashBackground: Palliative chemotherapy +/− targeted therapy in accordance with mutation profile is the norm in nonsmall-cell lung cancer (NSCLC). The objective of this audit was to determine the proportion of patients and physicians, who are unwilling to wait for the mutation report and the reasons thereof. Materials and Methods: All newly diagnosed NSCLC patients, post biopsy, seen at our center between November 2014 and January 2015 were included. The relationship between patient and physician decision and objective factors was explored by Fisher's exact test. The factors considered were Eastern Cooperative Oncology Group performance status (ECOG PS), the presence of a cough, hemoptysis, fatigue, and breathlessness. The agreement between patients and physician decision was tested by contingency table. Results: Out of 168 patients, 57 were unwilling to wait for driver mutation report (33.9% 95% confidence interval [CI] 27.2-41.4%). The most common reason provided by patients was symptomatic status (23, 40.1%). No other objective factor except PS (P = 0.00) was associated with patient's decision. In 56 patients (33.4% 95% CI 26.6-40.7%), physicians were unwilling to wait. Among the tested factors ECOG PS (P = 0.000), breathlessness (P = 0.00) and fatigue (P = 0.00) were associated with the decision of not waiting for the report. The percentage corrected value of contingency between patients and physician decision was 78.74%. Conclusion: At present, in our setup, nearly one-third of our NSCLC patients opt for immediate chemotherapy treatment and are unwilling to wait for mutation analysis report. The major reasons for such attitude is poor symptom control and deteriorating general condition.http://www.ijmpo.org/article.asp?issn=0971-5851;year=2016;volume=37;issue=2;spage=74;epage=78;aulast=JoshiAcceptance, delay, epidermal growth factor receptor mutation analysis, nonsmall-cell lung cancer, willingness |
| spellingShingle | Amit Joshi Vijay M Patil Vanita Noronha Joydeep Ghosh Atanu Bhattacharjee Kumar Prabhash A cross-sectional observation study regarding patients and their physician willingness to wait for driver mutation report in nonsmall-cell lung cancer Indian Journal of Medical and Paediatric Oncology Acceptance, delay, epidermal growth factor receptor mutation analysis, nonsmall-cell lung cancer, willingness |
| title | A cross-sectional observation study regarding patients and their physician willingness to wait for driver mutation report in nonsmall-cell lung cancer |
| title_full | A cross-sectional observation study regarding patients and their physician willingness to wait for driver mutation report in nonsmall-cell lung cancer |
| title_fullStr | A cross-sectional observation study regarding patients and their physician willingness to wait for driver mutation report in nonsmall-cell lung cancer |
| title_full_unstemmed | A cross-sectional observation study regarding patients and their physician willingness to wait for driver mutation report in nonsmall-cell lung cancer |
| title_short | A cross-sectional observation study regarding patients and their physician willingness to wait for driver mutation report in nonsmall-cell lung cancer |
| title_sort | cross sectional observation study regarding patients and their physician willingness to wait for driver mutation report in nonsmall cell lung cancer |
| topic | Acceptance, delay, epidermal growth factor receptor mutation analysis, nonsmall-cell lung cancer, willingness |
| url | http://www.ijmpo.org/article.asp?issn=0971-5851;year=2016;volume=37;issue=2;spage=74;epage=78;aulast=Joshi |
| work_keys_str_mv | AT amitjoshi acrosssectionalobservationstudyregardingpatientsandtheirphysicianwillingnesstowaitfordrivermutationreportinnonsmallcelllungcancer AT vijaympatil acrosssectionalobservationstudyregardingpatientsandtheirphysicianwillingnesstowaitfordrivermutationreportinnonsmallcelllungcancer AT vanitanoronha acrosssectionalobservationstudyregardingpatientsandtheirphysicianwillingnesstowaitfordrivermutationreportinnonsmallcelllungcancer AT joydeepghosh acrosssectionalobservationstudyregardingpatientsandtheirphysicianwillingnesstowaitfordrivermutationreportinnonsmallcelllungcancer AT atanubhattacharjee acrosssectionalobservationstudyregardingpatientsandtheirphysicianwillingnesstowaitfordrivermutationreportinnonsmallcelllungcancer AT kumarprabhash acrosssectionalobservationstudyregardingpatientsandtheirphysicianwillingnesstowaitfordrivermutationreportinnonsmallcelllungcancer AT amitjoshi crosssectionalobservationstudyregardingpatientsandtheirphysicianwillingnesstowaitfordrivermutationreportinnonsmallcelllungcancer AT vijaympatil crosssectionalobservationstudyregardingpatientsandtheirphysicianwillingnesstowaitfordrivermutationreportinnonsmallcelllungcancer AT vanitanoronha crosssectionalobservationstudyregardingpatientsandtheirphysicianwillingnesstowaitfordrivermutationreportinnonsmallcelllungcancer AT joydeepghosh crosssectionalobservationstudyregardingpatientsandtheirphysicianwillingnesstowaitfordrivermutationreportinnonsmallcelllungcancer AT atanubhattacharjee crosssectionalobservationstudyregardingpatientsandtheirphysicianwillingnesstowaitfordrivermutationreportinnonsmallcelllungcancer AT kumarprabhash crosssectionalobservationstudyregardingpatientsandtheirphysicianwillingnesstowaitfordrivermutationreportinnonsmallcelllungcancer |